Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
Western biopharma companies are increasingly sourcing innovation from China as a wave of patent expirations approaches.
Written by EGazette’s AI. The facts are drawn from cited sources; the analysis is the AI’s own.
Major Western pharmaceutical companies are increasingly turning to China as a source of new drug candidates, as the industry faces a looming "patent cliff" that threatens revenue from existing blockbuster treatments.
The patent cliff refers to the expiration of patents protecting a number of major drugs, which will expose these products to generic competition and significant revenue losses for the companies that developed them.
In response, biopharma firms have pursued multibillion-dollar licensing and acquisition deals to secure promising compounds developed by Chinese biotech companies, seeking to replenish their pipelines.
The trend reflects a broader shift in where pharmaceutical innovation is being sourced, with Chinese biotech firms increasingly recognized for developing competitive drug candidates at lower cost than their Western counterparts.
Analysts expect the pace of such deals to continue as Western companies look to offset the financial impact of upcoming patent expirations through partnerships with Chinese drug developers.
Sources
- Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals — CNBC — Top News
EGazette summarizes reporting from multiple sources; follow the links for the originals.
Comments
Loading comments…
Related articles
Big Pharma's China Deal Spree Grows With Latest Tie-Up Worth Up to $7.8 Billion
Western biopharmaceutical companies are increasingly turning to China to source innovation as the industry's looming patent cliff draws closer, according to CNBC.
Tesla shares jump 5% after better-than-expected vehicle delivery report
The stock rose even as Tesla's core automotive business faces growing pressure from affordable, innovative electric vehicles rolled out by Chinese and European carmakers.
Taiwan Coast Guard uses water cannon on Chinese fishing boats near Dongsha Islands
Taiwan's Coast Guard drove two Chinese fishing boats away from waters near the Dongsha Islands using a water cannon, Al Jazeera reported.
Lilly and Novo Nordisk turn to amylin drugs for next wave of obesity treatments
Both drugmakers are developing amylin-based therapies as a new biological approach to treating obesity and diabetes beyond GLP-1 drugs.
US reportedly to deploy anti-ship missiles near Taiwan for the first time
Media reports say the system will be stationed on Japan's Yonaguni island during the Keen Sword military exercise.
Price of Russian Gas Exports to China Projected to Rise in 2026 and 2027
A baseline forecast points to a 3% price increase in 2026 and a further 1.4% rise in 2027 for gas supplied to China.